欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0256/001
药品名称Irinoliquid 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
活性成分
    • irinotecan hydrochloride 20.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Ebewe Pharma Ges.m.h.Nfg.KG Mondseestrasse 11 4866 Unterach Austria
参考成员国 - 产品名称Austria (AT)
Irinoliquid 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Greece (GR)
    • Hungary (HU)
      IRINOTECAN "EBEWE" 20 mg/ml koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Irinotecan EBEWE
    • Cyprus (CY)
      IRINOTECAN EBEWE 20mg/ml CON. FOR SOLUTION FOR INFUSION
    • Malta (MT)
    • Poland (PL)
    • Belgium (BE)
    • Latvia (LV)
    • United Kingdom (Northern Ireland) (XI)
    • Estonia (EE)
    • Ireland (IE)
许可日期2010/03/17
最近更新日期2024/05/28
药物ATC编码
    • L01XX19 irinotecan
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase